Twist Bioscience (TWST) Assets Average (2018 - 2026)

Twist Bioscience (TWST) has reported Assets Average for 9 consecutive years, with $674.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average rose 8.83% year-over-year to $674.3 million in Q2 2026; TTM through Jun 2026 was $674.3 million, a 8.83% increase from a year earlier, with the FY2025 full-year figure at $628.1 million, down 9.67% from the prior year.
• Assets Average was $674.3 million for Q2 2026 at Twist Bioscience, up from $657.1 million in the prior quarter.
• Over five years, Assets Average peaked at $1.0 billion in Q2 2022 and troughed at $602.1 million in Q1 2025.
• A 5-year average of $751.9 million and a median of $696.1 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 42.69% in 2022 and decreased 21.07% in 2024, its largest moves.
• Over 5 years, Assets Average stood at $935.7 million in 2022, then dropped by 19.35% to $754.6 million in 2023, then slipped by 18.97% to $611.5 million in 2024, then increased by 4.66% to $640.0 million in 2025, then climbed by 5.37% to $674.3 million in 2026.
• The last three Assets Average figures came in at $674.3 million (Q2 2026), $657.1 million (Q1 2026), and $640.0 million (Q4 2025), per Business Quant data.